Georgia House Bill 968 contains language that would add kratom compounds to the list of Schedule I controlled substances, and at the same time restrict the sale of kratom to over-the-counter sales in pharmacies. One problem with this bill: It is legally impossible. Under HB 968, the pharmacy sales provision for kratom is designed to allow …
On June 2, 2025, a last-minute amendment to ban kratom was slipped into a Connecticut hemp regulation bill that had originally been introduced on February 2. By June 4, the bill was sitting on Governor Ned Lamont’s desk. Lamont signed the bill into law three weeks later. The next step was to determine which schedule …
Connecticut Moves Forward with Kratom Ban Despite Majority Public Opposition Read More »
Since the Food and Drug Administration’s (FDA) July 29 announcement recommending 7-hydroxymitragynine (7-OH) become a Schedule I controlled substance, many counties, cities, and towns have reacted by announcing possible bans on 7-OH, but also on plain leaf kratom, which the FDA said it is not targeting. Local municipalities have been enacting bans for years, most …
U.S. Municipalities Escalate Crackdowns on Kratom and 7-OH Read More »
A Kratom Consumer Protection Act (KCPA) bill that would regulate the distribution, sale, and manufacture of kratom products is being considered in the Michigan House. House Bill 4969 would: Given the 2% limit, this Kratom Consumer Protection Act and others effectively outlaw the sale of novel 7-hydroxymitragynine (7-OH) products that have been widely available since …
Missouri is the latest state examining possible government action against both kratom and 7-hydroxymitragynine (7-OH) since the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) recommended that 7-OH, but not kratom, be placed on the national list of Schedule I controlled substances. Missouri Attorney General Catherine Hanaway announced on …
Missouri Attorney General Launches Investigation into Kratom, 7-OH Companies Read More »